Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy

Article

关键词: LEFT-VENTRICULAR DYSSYNCHRONY;    PREDICT ACUTE RESPONSE;    HEART-FAILURE PATIENTS;    CLINICAL IMPROVEMENT;    SYSTOLIC ASYNCHRONY;    RADIAL STRAIN;    QRS COMPLEXES;    SCAR TISSUE;    VELOCITY;    BENEFITS;   

DOI  :  10.1161/CIRCULATIONAHA.109.910778

来源: SCIE

【 摘 要 】

Background-Numerous criteria believed to define a positive response to cardiac resynchronization therapy have been used in the literature. No study has investigated agreement among these response criteria. We hypothesized that the agreement among the various response criteria would be poor. Methods and Results-A literature search was conducted with the keywords cardiac resynchronization and response. The 50 publications with the most citations were reviewed. After the exclusion of editorials and reviews, 17 different primary response criteria were identified from 26 relevant articles. The agreement among 15 of these 17 response criteria was assessed in 426 patients from the Predictors of Response to Cardiac Resynchronization Therapy (PROSPECT) study with Cohen's kappa-coefficient (2 response criteria were not calculable from PROSPECT data). The overall response rate ranged from 32% to 91% for the 15 response criteria. Ninety-nine percent of patients showed a positive response according to at least 1 of the 15 criteria, whereas 94% were classified as a nonresponder by at least 1 criterion. kappa-Values were calculated for all 105 possible comparisons among the 15 response criteria and classified into standard ranges: Poor agreement (kappa <= 0.4), moderate agreement (0.4= 0.75). Seventy-five percent of the comparisons showed poor agreement, 21% showed moderate agreement, and only 4% showed strong agreement. Conclusions-The 26 most-cited publications on predicting response to cardiac resynchronization therapy define response using 17 different criteria. Agreement between different methods to define response to cardiac resynchronization therapy is poor 75% of the time and strong only 4% of the time, which severely limits the ability to generalize results over multiple studies. (Circulation. 2010;121:1985-1991.)

【 授权许可】

Free